The 2016 Disruptive Growth & Healthcare Conference will feature presentations from CEOs, CFOs, COOs and CMOs of life science companies focusing on solutions to unmet medical needs and growth companies with disruptive technologies and business models. Attendees will include over 400 institutional investors, accredited investors, family offices, analysts, registered investment advisors, wealth managers, Source reps and their clients. The panels will cover disruptive innovations and business models, regenerative medicine, immunotherapy, grant writing, and finally a discussion regarding NOLs and rights offerings.